Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting

DOI record: { "DOI": "10.1016/j.intimp.2021.107636", "ISSN": [ "1567-5769" ], "URL": "http://dx.doi.org/10.1016/j.intimp.2021.107636", "alternative-id": [ "S1567576921002721" ], "article-number": "107636", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting" }, { "label": "Journal Title", "name": "journaltitle", "value": "International Immunopharmacology" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.intimp.2021.107636" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2021 Elsevier B.V. All rights reserved." } ], "author": [ { "affiliation": [], "family": "Mokhtari", "given": "Majid", "sequence": "first" }, { "affiliation": [], "family": "Mohraz", "given": "Minoo", "sequence": "additional" }, { "affiliation": [], "family": "Gouya", "given": "Mohammad Mehdi", "sequence": "additional" }, { "affiliation": [], "family": "Namdari Tabar", "given": "Hengameh", "sequence": "additional" }, { "affiliation": [], "family": "Tabrizi", "given": "Jafar-Sadegh", "sequence": "additional" }, { "affiliation": [], "family": "Tayeri", "given": "Katayoun", "sequence": "additional" }, { "affiliation": [], "family": "Aghamohamadi", "given": "Saeide", "sequence": "additional" }, { "affiliation": [], "family": "Rajabpoor", "given": "Zahra", "sequence": "additional" }, { "affiliation": [], "family": "Karami", "given": "Manoochehr", "sequence": "additional" }, { "affiliation": [], "family": "Raeisi", "given": "Alireza", "sequence": "additional" }, { "affiliation": [], "family": "Rahmani", "given": "Hamid", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-1590-6396", "affiliation": [], "authenticated-orcid": false, "family": "Khalili", "given": "Hossein", "sequence": "additional" } ], "container-title": "International Immunopharmacology", "container-title-short": "International Immunopharmacology", "content-domain": { "crossmark-restriction": true, "domain": [ "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2021, 4, 6 ] ], "date-time": "2021-04-06T17:50:30Z", "timestamp": 1617731430000 }, "deposited": { "date-parts": [ [ 2023, 4, 15 ] ], "date-time": "2023-04-15T09:14:37Z", "timestamp": 1681550077000 }, "indexed": { "date-parts": [ [ 2024, 3, 19 ] ], "date-time": "2024-03-19T11:02:49Z", "timestamp": 1710846169110 }, "is-referenced-by-count": 11, "issued": { "date-parts": [ [ 2021, 7 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 7, 1 ] ], "date-time": "2021-07-01T00:00:00Z", "timestamp": 1625097600000 } }, { "URL": "https://doi.org/10.15223/policy-017", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 7, 1 ] ], "date-time": "2021-07-01T00:00:00Z", "timestamp": 1625097600000 } }, { "URL": "https://doi.org/10.15223/policy-037", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 7, 1 ] ], "date-time": "2021-07-01T00:00:00Z", "timestamp": 1625097600000 } }, { "URL": "https://doi.org/10.15223/policy-012", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 7, 1 ] ], "date-time": "2021-07-01T00:00:00Z", "timestamp": 1625097600000 } }, { "URL": "https://doi.org/10.15223/policy-029", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 7, 1 ] ], "date-time": "2021-07-01T00:00:00Z", "timestamp": 1625097600000 } }, { "URL": "https://doi.org/10.15223/policy-004", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2021, 7, 1 ] ], "date-time": "2021-07-01T00:00:00Z", "timestamp": 1625097600000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S1567576921002721?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S1567576921002721?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "107636", "prefix": "10.1016", "published": { "date-parts": [ [ 2021, 7 ] ] }, "published-print": { "date-parts": [ [ 2021, 7 ] ] }, "publisher": "Elsevier BV", "reference": [ { "key": "10.1016/j.intimp.2021.107636_b0005", "unstructured": "WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/ (accessed on February 5, 2021)." }, { "DOI": "10.1093/cid/ciaa237", "article-title": "In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)", "author": "Yao", "doi-asserted-by": "crossref", "first-page": "732", "issue": "15", "journal-title": "Clin. Infect. Dis.", "key": "10.1016/j.intimp.2021.107636_b0010", "volume": "71", "year": "2020" }, { "DOI": "10.1016/j.ijantimicag.2020.105949", "article-title": "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial", "author": "Gautret", "doi-asserted-by": "crossref", "issue": "1", "journal-title": "Int. J. Antimicrob. Agents.", "key": "10.1016/j.intimp.2021.107636_b0015", "volume": "56", "year": "2020" }, { "article-title": "A first draft of the history of treating coronavirus disease 2019 (COVID-19): Use of repurposed medications in United States hospitals", "author": "Clancy", "journal-title": "Open Forum Infect. Dis.", "key": "10.1016/j.intimp.2021.107636_b0020", "year": "2020" }, { "DOI": "10.1056/NEJMoa2012410", "article-title": "Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19", "author": "Geleris", "doi-asserted-by": "crossref", "first-page": "2411", "issue": "25", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.intimp.2021.107636_b0025", "volume": "382", "year": "2020" }, { "DOI": "10.1056/NEJMoa2022926", "doi-asserted-by": "crossref", "key": "10.1016/j.intimp.2021.107636_b0030", "unstructured": "RECOVERY Collaborative Group, Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, Wiselka M, Ustianowski A, Elmahi E, Prudon B, Whitehouse T, Felton T, Williams J, Faccenda J, Underwood J, Baillie JK, Chappell LC, Faust SN, Jaki T, Jeffery K, Lim WS, Montgomery A, Rowan K, Tarning J, Watson JA, White NJ, Juszczak E, Haynes R, Landray MJ. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl. J. Med. 2020 Nov 19;383(21):2030-2040. doi: 10.1056/NEJMoa2022926." }, { "DOI": "10.1056/NEJMoa2023184", "doi-asserted-by": "crossref", "key": "10.1016/j.intimp.2021.107636_b0035", "unstructured": "WHO Solidarity Trial Consortium, Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, Abdool Karim Q, Alejandria MM, Hernández García C, Kieny MP, Malekzadeh R, Murthy S, Reddy KS, Roses Periago M, Abi Hanna P, Ader F, Al-Bader AM, Alhasawi A, Allum E, Alotaibi A, Alvarez-Moreno CA, Appadoo S, Asiri A, Aukrust P, Barratt-Due A, Bellani S, Branca M, Cappel-Porter HBC, Cerrato N, Chow TS, Como N, Eustace J, García PJ, Godbole S, Gotuzzo E, Griskevicius L, Hamra R, Hassan M, Hassany M, Hutton D, Irmansyah I, Jancoriene L, Kirwan J, Kumar S, Lennon P, Lopardo G, Lydon P, Magrini N, Maguire T, Manevska S, Manuel O, McGinty S, Medina MT, Mesa Rubio ML, Miranda-Montoya MC, Nel J, Nunes EP, Perola M, Portolés A, Rasmin MR, Raza A, Rees H, Reges PPS, Rogers CA, Salami K, Salvadori MI, Sinani N, Sterne JAC, Stevanovikj M, Tacconelli E, Tikkinen KAO, Trelle S, Zaid H, Røttingen JA, Swaminathan S. Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl. J. Med. 2020 Dec 2. doi: 10.1056/NEJMoa2023184." }, { "key": "10.1016/j.intimp.2021.107636_b0040", "unstructured": "COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/. Updated on 9 Oct 2020. (accessed on 16 Dec 2020)." }, { "article-title": "Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19", "author": "Bhimraj", "first-page": "2020", "journal-title": "Clin. Infect. Dis.", "key": "10.1016/j.intimp.2021.107636_b0045", "volume": "ciaa478", "year": "2020" }, { "DOI": "10.1001/jama.2020.8630", "article-title": "Association of Treatment with Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State", "author": "Rosenberg", "doi-asserted-by": "crossref", "first-page": "2493", "issue": "24", "journal-title": "JAMA", "key": "10.1016/j.intimp.2021.107636_b0050", "volume": "323", "year": "2020" }, { "DOI": "10.1001/jamacardio.2020.1787", "article-title": "Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit", "author": "Bessière", "doi-asserted-by": "crossref", "first-page": "1067", "issue": "9", "journal-title": "JAMA Cardiol.", "key": "10.1016/j.intimp.2021.107636_b0055", "volume": "5", "year": "2020" }, { "DOI": "10.1001/jamacardio.2020.1834", "article-title": "Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)", "author": "Mercuro", "doi-asserted-by": "crossref", "first-page": "1036", "issue": "9", "journal-title": "JAMA Cardiol.", "key": "10.1016/j.intimp.2021.107636_b0060", "volume": "5", "year": "2020" }, { "DOI": "10.1001/jama.2020.22240", "doi-asserted-by": "crossref", "key": "10.1016/j.intimp.2021.107636_b0065", "unstructured": "Self WH, Semler MW, Leither LM, Casey JD, Angus DC, Brower RG, Chang SY, Collins SP, Eppensteiner JC, Filbin MR, Files DC, Gibbs KW, Ginde AA, Gong MN, Harrell FE Jr, Hayden DL, Hough CL, Johnson NJ, Khan A, Lindsell CJ, Matthay MA, Moss M, Park PK, Rice TW, Robinson BRH, Schoenfeld DA, Shapiro NI, Steingrub JS, Ulysse CA, Weissman A, Yealy DM, Thompson BT, Brown SM; National Heart, Lung, and Blood Institute PETAL Clinical Trials Network, Steingrub J, Smithline H, Tiru B, Tidswell M, Kozikowski L, Thornton-Thompson S, De Souza L, Hou P, Baron R, Massaro A, Aisiku I, Fredenburgh L, Seethala R, Johnsky L, Riker R, Seder D, May T, Baumann M, Eldridge A, Lord C, Shapiro N, Talmor D, O’Mara T, Kirk C, Harrison K, Kurt L, Schermerhorn M, Banner-Goodspeed V, Boyle K, Dubosh N, Filbin M, Hibbert K, Parry B, Lavin-Parsons K, Pulido N, Lilley B, Lodenstein C, Margolin J, Brait K, Jones A, Galbraith J, Peacock R, Nandi U, Wachs T, Matthay M, Liu K, Kangelaris K, Wang R, Calfee C, Yee K, Hendey G, Chang S, Lim G, Qadir N, Tam A, Beutler R, Levitt J, Wilson J, Rogers A, Vojnik R, Roque J, Albertson T, Chenoweth J, Adams J, Pearson S, Juarez M, Almasri E, Fayed M, Hughes A, Hillard S, Huebinger R, Wang H, Vidales E, Patel B, Ginde A, Moss M, Baduashvili A, McKeehan J, Finck L, Higgins C, Howell M, Douglas I, Haukoos J, Hiller T, Lyle C, Cupelo A, Caruso E, Camacho C, Gravitz S, Finigan J, Griesmer C, Park P, Hyzy R, Nelson K, McDonough K, Olbrich N, Williams M, Kapoor R, Nash J, Willig M, Ford H, Gardner-Gray J, Ramesh M, Moses M, Ng Gong M, Aboodi M, Asghar A, Amosu O, Torres M, Kaur S, Chen JT, Hope A, Lopez B, Rosales K, Young You J, Mosier J, Hypes C, Natt B, Borg B, Salvagio Campbell E, Hite RD, Hudock K, Cresie A, Alhasan F, Gomez-Arroyo J, Duggal A, Mehkri O, Hastings A, Sahoo D, Abi Fadel F, Gole S, Shaner V, Wimer A, Meli Y, King A, Terndrup T, Exline M, Pannu S, Robart E, Karow S, Hough C, Robinson B, Johnson N, Henning D, Campo M, Gundel S, Seghal S, Katsandres S, Dean S, Khan A, Krol O, Jouzestani M, Huynh P, Weissman A, Yealy D, Scholl D, Adams P, McVerry B, Huang D, Angus D, Schooler J, Moore S, Files C, Miller C, Gibbs K, LaRose M, Flores L, Koehler L, Morse C, Sanders J, Langford C, Nanney K, MdalaGausi M, Yeboah P, Morris P, Sturgill J, Seif S, Cassity E, Dhar S, de Wit M, Mason J, Goodwin A, Hall G, Grady A, Chamberlain A, Brown S, Bledsoe J, Leither L, Peltan I, Starr N, Fergus M, Aston V, Montgomery Q, Smith R, Merrill M, Brown K, Armbruster B, Harris E, Middleton E, Paine R, Johnson S, Barrios M, Eppensteiner J, Limkakeng A, McGowan L, Porter T, Bouffler A, Leahy JC, deBoisblanc B, Lammi M, Happel K, Lauto P, Self W, Casey J, Semler M, Collins S, Harrell F, Lindsell C, Rice T, Stubblefield W, Gray C, Johnson J, Roth M, Hays M, Torr D, Zakaria A, Schoenfeld D, Thompson T, Hayden D, Ringwood N, Oldmixon C, Ulysse C, Morse R, Muzikansky A, Fitzgerald L, Whitaker S, Lagakos A, Brower R, Reineck L, Aggarwal N, Bienstock K, Freemer M, Maclawiw M, Weinmann G, Morrison L, Gillespie M, Kryscio R, Brodie D, Zareba W, Rompalo A, Boeckh M, Parsons P, Christie J, Hall J, Horton N, Zoloth L, Dickert N, Diercks D. Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial. JAMA. 2020 Dec 1;324(21):2165-2176. doi: 10.1001/jama.2020.22240." }, { "article-title": "Hydroxychloroquine safety outcome with an approved therapeutic protocol for COVID-19 outpatients in Saudi Arabia", "author": "Mohana", "first-page": "110", "issue": "102", "journal-title": "Int. J. Infect. Dis.", "key": "10.1016/j.intimp.2021.107636_b0070", "volume": "17", "year": "2020" }, { "article-title": "Characteristics and Mortality of Hospitalized Patients With COVID-19 in Iran: A National Retrospective Cohort Study", "author": "Jalili", "first-page": "M20", "journal-title": "Ann. Intern. Med.", "key": "10.1016/j.intimp.2021.107636_b0075", "volume": "20", "year": "2020" }, { "DOI": "10.34172/aim.2020.01", "article-title": "IR of Iran National Mobilization against COVID-19 Epidemic", "author": "Raeisi", "doi-asserted-by": "crossref", "first-page": "216", "issue": "4", "journal-title": "Arch Iran Med.", "key": "10.1016/j.intimp.2021.107636_b0080", "volume": "23", "year": "2020" }, { "key": "10.1016/j.intimp.2021.107636_b0085", "unstructured": "National guidance of diagnosis and treatment of COVID-19 in both inpatient and outpatients setting. https://medcare.behdasht.gov.ir/. Updated on 13 Dec 2020 (accessed on 19 Dec 2020)." }, { "DOI": "10.1056/NEJMcp2009249", "article-title": "Mild or Moderate Covid-19", "author": "Gandhi", "doi-asserted-by": "crossref", "first-page": "1757", "issue": "18", "journal-title": "N. Engl. J. Med.", "key": "10.1016/j.intimp.2021.107636_b0090", "volume": "383", "year": "2020" }, { "DOI": "10.1016/j.ijantimicag.2020.106214", "article-title": "COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study", "author": "Derwand", "doi-asserted-by": "crossref", "issue": "6", "journal-title": "Int. J. Antimicrob. Agents", "key": "10.1016/j.intimp.2021.107636_b0095", "volume": "56", "year": "2020" }, { "article-title": "Risk of hospitalization for Covid-19 outpatients treated with various drug regimens in Brazil: Comparative analysis", "author": "Szente Fonseca", "issue": "38", "journal-title": "Travel Med. Infect. Dis.", "key": "10.1016/j.intimp.2021.107636_b0100", "volume": "31", "year": "2020" }, { "DOI": "10.1101/2020.08.20.20178772", "doi-asserted-by": "crossref", "key": "10.1016/j.intimp.2021.107636_b0105", "unstructured": "Ip A, Ahn J, Zhou Y, Goy AH, Hansen E, Pecora AL, Sinclaire BA, Bednarz U, Marafelias M, Mathura S, Sawczuk IS, Underwood III JP, Walker DM, Prasad R, Sweeney RL, Ponce MG, LaCapra S, Cunningham FJ, Calise AG, Pulver BL, Ruocco D, Mojares GE, Eagan MP, Ziontz KL, Mastrokyriakos P, Goldberg SL. Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study. medRxiv preprints 2020; August 25. https://doi.org/10.1101/2020.08.20.20178772." }, { "DOI": "10.1186/s12913-021-06126-8", "article-title": "The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran", "author": "Ghaffari Darab", "doi-asserted-by": "crossref", "first-page": "132", "issue": "1", "journal-title": "BMC Health Serv Res.", "key": "10.1016/j.intimp.2021.107636_b0110", "volume": "21", "year": "2021" }, { "DOI": "10.1016/j.nmni.2020.100776", "article-title": "Hydroxychloroquine is effective, and consistently so when provided early, for COVID-19: a systematic review", "author": "Prodromos", "doi-asserted-by": "crossref", "journal-title": "New Microbes New Infect.", "key": "10.1016/j.intimp.2021.107636_b0115", "volume": "38", "year": "2020" }, { "DOI": "10.1186/s13063-020-04556-z", "article-title": "Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial", "author": "Göpel", "doi-asserted-by": "crossref", "first-page": "635", "issue": "1", "journal-title": "Trials.", "key": "10.1016/j.intimp.2021.107636_b0120", "volume": "21", "year": "2020" }, { "DOI": "10.1186/s13063-020-04619-1", "doi-asserted-by": "crossref", "key": "10.1016/j.intimp.2021.107636_b0125", "unstructured": "Duvignaud A, Lhomme E, Pistone T, Onaisi R, Sitta R, Journot V, Nguyen D, Peiffer-Smadja N, Crémer A, Bouchet S, Darnaud T, Poitrenaud D, Piroth L, Binquet C, Michel JF, Lefèvre B, Lebeaux D, Lebel J, Dupouy J, Roussillon C, Gimbert A, Wittkop L, Thiébaut R, Orne-Gliemann J, Joseph JP, Richert L, Anglaret X, Malvy D; COVERAGE study group. Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial). Trials. 2020 Oct 13;21(1):846. doi: 10.1186/s13063-020-04619-1." }, { "DOI": "10.1093/cid/ciaa1009", "doi-asserted-by": "crossref", "key": "10.1016/j.intimp.2021.107636_b0130", "unstructured": "Mitjà O, Corbacho-Monné M, Ubals M, Tebe C, Peñafiel J, Tobias A, Ballana E, Alemany A, Riera-Martí N, Pérez CA, Suñer C, Laporte P, Admella P, Mitjà J, Clua M, Bertran L, Sarquella M, Gavilán S, Ara J, Argimon JM, Casabona J, Cuatrecasas G, Cañadas P, Elizalde-Torrent A, Fabregat R, Farré M, Forcada A, Flores-Mateo G, Muntada E, Nadal N, Narejos S, Gil-Ortega AN, Prat N, Puig J, Quiñones C, Reyes-Ureña J, Ramírez-Viaplana F, Ruiz L, Riveira-Muñoz E, Sierra A, Velasco C, Vivanco-Hidalgo RM, Sentís A, G-Beiras C, Clotet B, Vall-Mayans M; BCN PEP-CoV-2 RESEARCH GROUP. Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial. Clin Infect Dis. 2020 Jul 16:ciaa1009. doi: 10.1093/cid/ciaa1009." }, { "DOI": "10.7326/M20-4207", "article-title": "Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial", "author": "Skipper", "doi-asserted-by": "crossref", "first-page": "623", "issue": "8", "journal-title": "Ann. Intern. Med.", "key": "10.1016/j.intimp.2021.107636_b0135", "volume": "173", "year": "2020" }, { "article-title": "Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19. Open Forum", "author": "Lofgren", "journal-title": "Infect Dis.", "key": "10.1016/j.intimp.2021.107636_b0140", "year": "2020" }, { "DOI": "10.1016/j.tmaid.2020.101738", "doi-asserted-by": "crossref", "key": "10.1016/j.intimp.2021.107636_b0145", "unstructured": "Million M, Lagier JC, Gautret P, Colson P, Fournier PE, Amrane S, Hocquart M, Mailhe M, Esteves-Vieira V, Doudier B, Aubry C, Correard F, Giraud-Gatineau A, Roussel Y, Berenger C, Cassir N, Seng P, Zandotti C, Dhiver C, Ravaux I, Tomei C, Eldin C, Tissot-Dupont H, Honoré S, Stein A, Jacquier A, Deharo JC, Chabrière E, Levasseur A, Fenollar F, Rolain JM, Obadia Y, Brouqui P, Drancourt M, La Scola B, Parola P, Raoult D. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May-Jun;35:101738. doi: 10.1016/j.tmaid.2020.101738." }, { "DOI": "10.1016/j.tmaid.2020.101791", "doi-asserted-by": "crossref", "key": "10.1016/j.intimp.2021.107636_b0150", "unstructured": "Lagier JC, Million M, Gautret P, Colson P, Cortaredona S, Giraud-Gatineau A, Honoré S, Gaubert JY, Fournier PE, Tissot-Dupont H, Chabrière E, Stein A, Deharo JC, Fenollar F, Rolain JM, Obadia Y, Jacquier A, La Scola B, Brouqui P, Drancourt M, Parola P, Raoult D; IHU COVID-19 Task force. Outcomes of 3737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. 2020 Jul-Aug;36:101791. doi: 10.1016/j.tmaid.2020.101791." } ], "reference-count": 30, "references-count": 30, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S1567576921002721" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Pharmacology", "Immunology", "Immunology and Allergy" ], "subtitle": [], "title": "Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "volume": "96" }